leadf
logo-loader
viewAqualung Therapeutics

Aqualung seeking $15M in Series A funding to manufacture its drug to treat inflammatory diseases

Aqualung Therapeutics Corp CEO Dr "Skip" Garcia joined Proactive at the Biotech Showcase 2020 in San Francisco. The Arizona-based, privately-held early stage biotech company is involved in the treatment of inflammatory diseases, and is seeking $50M in Series A funding to manufacture its drug.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Lotus Resources reveals highlights on scoping study at its Kayelekera...

Lotus Resources Ltd (ASX:LOT) Managing Director Eduard Smirnov tells Proactive the group's Kayelekera Uranium Project can be among first uranium projects to begin production to meet the impending uranium supply shortfall. Smirnov says according to the study, the project will have a long mine...

5 hours, 26 minutes ago

2 min read